Description
Retatrutide’s mechanism of action targets key metabolic pathways by activating the GLP-1 receptor to drive insulin secretion, suppress glucagon release, and improve glucose homeostasis. The GIP receptor co-agonism enhances insulin secretion while also impacting adipose tissue and appetite regulation. The addition of glucagon receptor agonism stimulates energy expenditure, contributing to thermogenesis and hepatic glucose regulation. Together, these three pathways make Retatrutide a promising peptide for studying metabolic parameters and the treatment of obesity and type 2 diabetes.
The 10mg vial of Retatrutide is ideal for researchers beginning investigations into incretin-based therapies, metabolic regulation, and obesity management. This vial size is suitable for in vitro receptor assays, cell-based studies, and early in vivo experiments in animal models, providing ample material for focused research without requiring larger quantities.
Progression Peptides offers Retatrutide as a high-purity lyophilized powder, with third-party purity verification ensuring that the peptide meets rigorous standards for consistency and reliability in research. The lyophilized form preserves the peptide’s stability and bioactivity when handled and stored according to recommended guidelines.
Reconstitution: Reconstitute with bacteriostatic water, allowing it to dissolve gently without agitation. The solution should remain clear and free from visible particles.
Storage: Store the lyophilized peptide at -20°C. Once reconstituted, refrigerate at 2-8°C and use within 30 days.
For research purposes only. Not for human consumption or veterinary use. Sold exclusively for laboratory and in vitro research.
Reviews
There are no reviews yet.